Advertisement
Advertisement

VRDN

VRDN logo

Viridian Therapeutics, Inc. Common Stock

17.70
USD
Sponsored
+0.66
+3.89%
May 14, 10:04 UTC -4
Open

Viridian Therapeutics, Inc. Common Stock Profile

About

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

Info & Links

CEO

Stephen Mahoney

Headquarters

221 CRESCENT STREET, SUITE 103A
WALTHAM, MA 02453, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.viridiantherapeutics.com

Auditor

KPMG LLP

Share holders

9

Employees

252

Viridian Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.82B

Enterprise Value

1.66B

Enterprise Value/EBITDA(ttm)

-4.50

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

22.19

Price to Book(mrq)

2.49

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-483.57%

Profit Margin(ttm)

-86562.98%

Return on Equity(ttm)

-83.25%

Return on Invested Capital(ttm)

-55.19%

Return on Assets(ttm)

-50.38%

Income Statement

Revenue(ttm)

70.85M

Revenue Per Share(ttm)

0.69

Gross Profit(ttm)

70.85M

EBITDA(ttm)3

-369.69M

Net Income Available to Common(ttm)

-342.60M

Diluted EPS(ttm)

-3.29

Share Statistics

Beta (5Y Monthly)

1.16

52-Week Change

38.20%

S&P 500 52-Week Change

26.85%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

102.21M

Dividend Yield

0.00%

Float4

100.59M

% Held by Insiders

1.58%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

874.65M

Total Cash Per Share(mrq)

8.56

Total Debt(mrq)

49.94M

Total Debt/Equity(mrq)

6.92%

Current Ratio(mrq)

12.65%

Quick Ratio(mrq)

12.65%

Book Value Per Share(mrq)

7.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.26

Free Cash Flow(ytd)

-276.89M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement